19.54
price up icon2.90%   0.55
after-market After Hours: 19.54
loading
Mediwound Ltd stock is traded at $19.54, with a volume of 54,974. It is up +2.90% in the last 24 hours and down -4.07% over the past month. MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$18.99
Open:
$19.39
24h Volume:
54,974
Relative Volume:
0.75
Market Cap:
$230.10M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-14.16
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
-1.21%
1M Performance:
-4.07%
6M Performance:
+9.22%
1Y Performance:
+34.57%
1-Day Range:
Value
$19.38
$19.87
1-Week Range:
Value
$18.50
$19.89
52-Week Range:
Value
$14.14
$24.00

Mediwound Ltd Stock (MDWD) Company Profile

Name
Name
Mediwound Ltd
Name
Phone
-
Name
Address
-
Name
Employee
111
Name
Twitter
Name
Next Earnings Date
2025-03-19
Name
Latest SEC Filings
Name
MDWD's Discussions on Twitter

Compare MDWD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MDWD
Mediwound Ltd
19.54 230.10M 19.85M -12.75M -21.94M -1.38
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.27 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
522.27 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.00 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
568.06 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
266.80 28.51B 3.81B -644.79M -669.77M -6.24

Mediwound Ltd Stock (MDWD) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-02-25 Resumed Oppenheimer Outperform
May-02-25 Initiated Alliance Global Partners Buy
Feb-28-25 Initiated Craig Hallum Buy
Jul-16-24 Reiterated Maxim Group Buy
Dec-22-22 Initiated Maxim Group Buy
Jul-18-22 Resumed Oppenheimer Outperform
Sep-23-20 Initiated BTIG Research Buy
Nov-28-16 Initiated Aegis Capital Buy
Aug-17-16 Initiated Wells Fargo Outperform
Apr-16-14 Initiated Oppenheimer Outperform
View All

Mediwound Ltd Stock (MDWD) Latest News

pulisher
Jun 17, 2025

Bank of America Corp DE Has $141,000 Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World

Jun 17, 2025
pulisher
Jun 15, 2025

(MDWD) On The My Stocks Page - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 05, 2025

Analysts Set MediWound Ltd. (NASDAQ:MDWD) PT at $31.25 - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

When (MDWD) Moves Investors should Listen - news.stocktradersdaily.com

Jun 03, 2025
pulisher
Jun 03, 2025

MediWound (NASDAQ:MDWD) Now Covered by Oppenheimer - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Oppenheimer assumes MediWound stock at outperform, sets $34 PT By Investing.com - Investing.com India

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer assumes MediWound stock at outperform, sets $34 PT - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer Adjusts MediWound Price Target to $34 From $36, Maintains Outperform Rating - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

MediWound (MDWD) Garners Outperform Rating with Strategic Advanc - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Companies Like MediWound (NASDAQ:MDWD) Are In A Position To Invest In Growth - Yahoo Finance

Jun 02, 2025
pulisher
May 26, 2025

What is HC Wainwright’s Forecast for MediWound Q2 Earnings? - Defense World

May 26, 2025
pulisher
May 25, 2025

Northern Trust Corp Has $2.58 Million Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World

May 25, 2025
pulisher
May 24, 2025

MediWound (NASDAQ:MDWD) PT Set at $31.00 by HC Wainwright - Defense World

May 24, 2025
pulisher
May 23, 2025

Where are the Opportunities in (MDWD) - news.stocktradersdaily.com

May 23, 2025
pulisher
May 23, 2025

H.C. Wainwright lifts MediWound stock target to $31, maintains buy By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 22, 2025

H.C. Wainwright lifts MediWound stock target to $31, maintains buy - Investing.com

May 22, 2025
pulisher
May 22, 2025

MDWD: HC Wainwright & Co. Raises Price Target for MediWound | MD - GuruFocus

May 22, 2025
pulisher
May 22, 2025

MediWound (MDWD) Target Price Raised by Analyst | MDWD Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

MediWound (MDWD) Target Price Raised by Analyst | MDWD Stock New - GuruFocus

May 22, 2025
pulisher
May 22, 2025

MediWound Ltd (MDWD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Decline - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

MediWound’s Q1 2025: Strategic Progress Amid Financial Challenges - TipRanks

May 22, 2025
pulisher
May 21, 2025

Mediwound earnings beat by $0.58, revenue fell short of estimates - Investing.com India

May 21, 2025
pulisher
May 21, 2025

MediWound (MDWD) Q1 2025 Earnings Call Transcript - Mitrade

May 21, 2025
pulisher
May 21, 2025

MediWound: Q1 Earnings Snapshot - MySA

May 21, 2025
pulisher
May 21, 2025

MediWound Q1 2025 Earnings Call Transcript - MarketBeat

May 21, 2025
pulisher
May 21, 2025

Transcript : MediWound Ltd., Q1 2025 Earnings Call, May 21, 2025 - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

MediWound Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

MediWound Ltd. Reaffirms Revenue Guidance for the Year 2025 - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

MediWound (MDWD) Projects Revenue Growth for Fiscal Year 2025 | - GuruFocus

May 21, 2025
pulisher
May 21, 2025

MediWound Announces Q1 2025 Results and Updates on Key Trials - TipRanks

May 21, 2025
pulisher
May 21, 2025

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

May 21, 2025
pulisher
May 21, 2025

MediWound (MDWD): Q1 Revenue Falls Short, Strategic Growth Plans Intact | MDWD Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

MediWound Expands Global Reach: Major Wound Care Players Join Clinical Trials as Revenue Targets $24M - Stock Titan

May 21, 2025
pulisher
May 21, 2025

Earnings To Watch: MediWound Ltd (MDWD) Reports Q1 2025 Result - GuruFocus

May 21, 2025
pulisher
May 16, 2025

MediWound Stock: Undervalued High-Growth Potential (NASDAQ:MDWD) - Seeking Alpha

May 16, 2025
pulisher
May 15, 2025

MediWound Announces Key Approvals at 2025 Shareholder Meeting - TipRanks

May 15, 2025
pulisher
May 14, 2025

We Think MediWound (NASDAQ:MDWD) Can Afford To Drive Business Growth - simplywall.st

May 14, 2025
pulisher
May 14, 2025

MediWound (MDWD) to Release Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

MediWound (MDWD) Showcases Phase II Trial Results in Wound Care - GuruFocus

May 14, 2025
pulisher
May 13, 2025

EscharEx shows promise in venous ulcer treatment - Investing.com Australia

May 13, 2025
pulisher
May 13, 2025

MediWound Announces Publication of Phase II EscharEx® Data Demon - GuruFocus

May 13, 2025
pulisher
May 13, 2025

MediWound Announces Publication of Phase II EscharEx® Data - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers - Stock Titan

May 13, 2025
pulisher
May 13, 2025

Barclays PLC Raises Stock Position in MediWound Ltd. (NASDAQ:MDWD) - Defense World

May 13, 2025
pulisher
May 07, 2025

MediWound Ltd. (NASDAQ:MDWD) Shares Sold by Renaissance Technologies LLC - Defense World

May 07, 2025

Mediwound Ltd Stock (MDWD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.74
price up icon 0.29%
$36.14
price up icon 2.09%
$20.92
price up icon 2.60%
$105.90
price up icon 0.46%
$105.09
price up icon 2.02%
biotechnology ONC
$266.80
price up icon 3.61%
Cap:     |  Volume (24h):